AMERSA

AMERSA

Call Us: (401) 615-4047 | Contact Us AMERSA on Twitter AMERSA on LinkedIn AMERSA on BlueSky

Make a Donation Pay a Past-Due Balance Join Our Mailing List
  • About
    • What is AMERSA
    • Board of Directors
    • Donate to AMERSA
    • Contact Us
  • Membership
    • Get to Know AMERSA
    • Join / Renew
    • Who We Are
    • Member Center
    • Special Interest Groups
    • Career Opportunities
    • Professional & Academic Advancement Opps
  • Conference
    • Annual Conference
    • Conference Sponsorship
    • Conference Exhibitor Information
    • Policy and Procedures for AMERSA Events
    • 2024 Conference Materials
    • Past Conference Resources
  • Journal
    • Journal Home
    • About Us
    • Member Access to Journal
    • Author Instructions and Submission
    • SAj Blog
    • SAj Annual Awards
    • SAj Editorial Scholar Program
  • Advocacy
    • AMERSA Advocacy
    • Position Statements
    • Submit a Position Statement
    • Letters of Support
    • Public Comments
  • Sustainability
    • Initiatives
    • Resources
  • Education
    • AMERSA Podcast Series
    • AMERSA Webinars
    • Core Competencies – AMERSA in the 21st Century
    • Resources
  • Awards
    • AMERSA Awards
    • Current Award Winners
    • Past Award Winners

The Authors’ Own Words: Buprenorphine Shared Medical Appointments for the Treatment of Opioid Dependence in a Homeless Clinic

Feb 8, 2020 by AMERSA

The Authors’ Own Words:  

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Buprenorphine Shared Medical Appointments for the Treatment of Opioid Dependence in a Homeless Clinic

Sara L. Doorley, MD; Cheryl J. Ho, MD; Elizabeth Echeverria, LCSW; Charles Preston, PhD; Huy Ngo, MD; Ahmad Kamal, MD, MSc; & Chinazo O. Cunningham, MD, MS

Substance Abuse Vol. 38, Iss. 1, 2017

“This manuscript describes a novel strategy to provide integrated, whole person care to homeless persons with opioid use disorders. The findings of this manuscript are noteworthy for the high treatment retention rates found at 12 and 24 weeks. These findings are even more noteworthy when considering the social and medical vulnerability of the individuals included in this preliminary evaluation. Furthermore, this manuscript contributes to the literature by exploring two areas of relative research paucity- buprenorphine treatment of homeless persons and office-based buprenorphine treatment using shared medical appointments.  The findings of this manuscript can help guide the development of unique treatment models to serve real-world, complex patients with opioid dependence and highlights how innovation and the provision of more than usual resources can achieve health equity for vulnerable patient populations disproportionately burdened by disease.”

Follow us on twitter to stay up to date with SAj, upcoming publications, and more!

Filed Under: SAj Blog, Uncategorized

Copyright © 2025
Site by: web360